Why Did Intellia Soar in 2021 While Other Gene Editing Stocks Faltered? Crispr in Humans

seekingalpha2021-12-29

Gene therapy-focused biotechs are engaged in the development of some of the most cutting-edge treatments. Yet only one has had astandout year: Intellia Therapeutics. While its peers are all in the red...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
4